In a competition assay, CV1-hIgG4 efficiently blocked interactions between anti-CD47 antibodies and CD47 expressed on human and canine melanoma cells (Supplemental digital content 3B and 3C, http://links.lww.com/MR/A160). Here, CD47 is linked to melanoma.